Related Experiment Video
Updated: Oct 6, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Fluvoxamine for symptomatic outpatients with COVID-19
Peter E Wu1, Emily Austin2, Derek Leong2
1Division of General Internal Medicine and Geriatrics (Wu), University Health Network; Division of Clinical Pharmacology and Toxicology (Wu), Department of Medicine, University of Toronto; Division of Emergency Medicine (Austin), St. Michael's Hospital; Ontario Poison Centre (Austin), Hospital for Sick Children; Department of Pharmacy (Leong), University Health Network, Toronto, Ont. peter.wu@uhn.ca.
No abstract available in PubMed .
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Antidepressant Drugs: Overview
Antipsychotic Drugs: Typical and Atypical Agents
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

